WCCT Global launches special population recruitment tool
WCCT Global, a CRO supporting phase I-IV biopharmaceutical and medical device development, has rolled out their special population Recruitment Management Tool (RMT) for early and late phase clinical studies.
Recruiting the right participants into a clinical trial is a fundamental and essential element for success that easily gets overlooked. WCCT Global has built a cutting edge recruitment tool in order to meet the needs of sponsors who have studies either competitively or non-competitively recruiting in any region of the country.
The WCCT Global RMT consists of a proprietary algorithm which combines multiple web technologies which enables recruiters to target specific patients needed for any project. Any geographic region or diagnostic category can be targeted. The recruiters can be centrally located while recruiting nationally, thus, using less resources and shortening overall recruitment times.
“I truly believe our new recruitment tool is raising the bar for all contract research organization’s recruitment efforts,” said Lee Barsky, vice president of program management, WCCT Global. “We are now able to precisely target the required resources to recruit specific patient populations anywhere in the U.S. in record time.”
WCCT Global has been able to successfully screen and randomize multiple special population clinical studies including Asian-bridging studies, difficult asthma studies, ophthalmology studies and infectious disease studies using this recruitment management tool and feels it is a must have for every clinical trial.